We are live on ! Find out more
HWM

Hohimer Wealth Management Portfolio holdings

AUM $847M
1-Year Est. Return 29.89%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+29.89%
3 Year Est. Return
+85.46%
5 Year Est. Return
+106.44%
10 Year Est. Return
AUM
$531M
AUM Growth
+$66.4M
Cap. Flow
+$59.8M
Cap. Flow %
11.26%
Top 10 Hldgs %
27.24%
Holding
264
New
37
Increased
139
Reduced
34
Closed
23

Top Sells

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$4.36M
2
SLB icon
SLB Ltd
SLB
+$4.07M
3
GILD icon
Gilead Sciences
GILD
+$3.8M
4
WBD icon
Warner Bros
WBD
+$3.61M
5
CPRI icon
Capri Holdings
CPRI
+$3.41M

Sector Composition

Rank Sector Weight
1 Technology 23.12%
2 Financials 12.02%
3 Healthcare 7.64%
4 Consumer Discretionary 7.39%
5 Industrials 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSIS icon
176
OSI Systems
OSIS
$3.53B
$310K 0.06%
1,850
+112
+6% +$17.8K
ACOG
177
Alpha Cognition
ACOG
$192M
$304K 0.06%
+51,608
New +$290K
NBN icon
178
Northeast Bank
NBN
$1.04B
$304K 0.06%
3,311
+143
+5% +$13.2K
ADUS icon
179
Addus HomeCare
ADUS
$2.22B
$302K 0.06%
2,409
+158
+7% +$20K
ETN icon
180
Eaton
ETN
$141B
$300K 0.06%
903
+14
+2% +$4.91K
HSII
181
DELISTED
Heidrick & Struggles
HSII
$291K 0.05%
+6,569
New +$281K
ATEN icon
182
A10 Networks
ATEN
$2.07B
$288K 0.05%
15,671
+2,044
+15% +$33.4K
ISTB icon
183
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
$288K 0.05%
6,032
-680
-10% -$32.6K
PRU icon
184
Prudential Financial
PRU
$42.6B
$288K 0.05%
2,430
INTC icon
185
Intel
INTC
$413B
$286K 0.05%
+14,255
New +$321K
MATX icon
186
Matsons
MATX
$6.11B
$281K 0.05%
2,083
+134
+7% +$19.5K
AMPH icon
187
Amphastar Pharmaceuticals
AMPH
$907M
$278K 0.05%
7,485
+491
+7% +$22.5K
ACN icon
188
Accenture
ACN
$106B
$277K 0.05%
788
ABBV icon
189
AbbVie
ABBV
$465B
$273K 0.05%
1,536
+104
+7% +$19.1K
SKYW icon
190
Skywest
SKYW
$4.35B
$271K 0.05%
2,703
+150
+6% +$15.3K
CLOZ icon
191
Panagram BBB-B CLO ETF
CLOZ
$783M
$270K 0.05%
10,000
FHI icon
192
Federated Hermes
FHI
$4.56B
$269K 0.05%
6,546
+334
+5% +$13.5K
QCRH icon
193
QCR Holdings
QCRH
$1.68B
$268K 0.05%
3,325
+186
+6% +$15.6K
JAKK icon
194
Jakks Pacific
JAKK
$303M
$266K 0.05%
9,465
+446
+5% +$12.2K
PLMR icon
195
Palomar
PLMR
$3.79B
$266K 0.05%
2,518
+150
+6% +$15.2K
FTDR icon
196
Frontdoor
FTDR
$5.27B
$263K 0.05%
4,815
+219
+5% +$11.9K
ANIP icon
197
ANI Pharmaceuticals
ANIP
$1.86B
$262K 0.05%
4,742
+319
+7% +$18.3K
RBCAA icon
198
Republic Bancorp
RBCAA
$1.96B
$258K 0.05%
3,692
+219
+6% +$15.6K
BOX icon
199
Box
BOX
$4.49B
$257K 0.05%
8,123
+990
+14% +$32.5K
CARG icon
200
CarGurus
CARG
$3.34B
$252K 0.05%
+6,909
New +$237K

Similar funds

Hohimer Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, Hohimer Wealth Management held 264 positions worth $531M, up 14% from $465M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Hohimer Wealth Management deployed $59.8M of net new capital in Q4 2024, opening 37 new positions and adding to 139 existing holdings. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 93,600 shares worth $5.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Royalty Pharma, an estimated $2.96M trimmed.

  • Hohimer Wealth Management's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 93,600 shares worth $5.7M.
  • Hohimer Wealth Management added most to Vanguard Short-Term Bond ETF in Q4 2024, an estimated $19.9M increase.
  • Hohimer Wealth Management's biggest Q4 2024 reduction was Royalty Pharma, cutting an estimated $2.96M.
  • Hohimer Wealth Management fully exited Conagra Brands in Q4 2024, selling an estimated $4.36M.
  • Hohimer Wealth Management's ten largest holdings make up 27% of its $531M portfolio in Q4 2024.
  • Hohimer Wealth Management opened 37 new positions and closed 23 in Q4 2024.
  • Hohimer Wealth Management's portfolio value rose 14% quarter-over-quarter to $531M.

Based on Hohimer Wealth Management's 13F filing for Q4 2024, filed 14 Feb 2025.